Search Results - "Abboud, Karen"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics by Abboud, Karen, Umoru, Godsfavour, Trachtenberg, Barry, Ajewole, Veronica

    Published in Cardio-oncology (London, England) (09-04-2024)
    “…Oral cancer therapy-related cardiovascular (CV) toxicity has a wide variety of presentations including arrhythmia, cardiomyopathy, and myocardial infarction,…”
    Get full text
    Journal Article
  2. 2

    Pancreatic ductal adenocarcinoma: the latest on diagnosis, molecular profiling, and systemic treatments by Bugazia, Doaa, Al-Najjar, Ebtesam, Esmail, Abdullah, Abdelrahim, Saifudeen, Abboud, Karen, Abdelrahim, Adham, Umoru, Godsfavour, Rayyan, Hashem A, Abudayyeh, Ala, Al Moustafa, Ala-Eddin, Abdelrahim, Maen

    Published in Frontiers in oncology (01-07-2024)
    “…Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth leading cause of death in the United States and is expected to be ranked second in the next 10…”
    Get full text
    Journal Article
  3. 3

    Pancreatic Tumorigenesis: Precursors, Genetic Risk Factors and Screening by Badheeb, Mohamed, Abdelrahim, Adham, Esmail, Abdullah, Umoru, Godsfavour, Abboud, Karen, Al-Najjar, Ebtesam, Rasheed, Ghaith, Alkhulaifawi, Mohammed, Abudayyeh, Ala, Abdelrahim, Maen

    Published in Current oncology (Toronto) (15-11-2022)
    “…Pancreatic cancer (PC) is a highly malignant and aggressive tumor. Despite medical advancement, the silent nature of PC results in only 20% of all cases…”
    Get full text
    Journal Article
  4. 4

    A Cross-Sectional Study Revealed a Low Prevalence of SARS-CoV-2 Infection among Asymptomatic University Students in Tripoli, North Lebanon by Rafei, Rayane, Tajer, Layla, Nour, Dalal, Abboud, Karen, Ankoud, Dima, Osman, Marwan, Bedotto, Marielle, Ismail, Mohamad Bachar, Dabboussi, Fouad, Colson, Philippe, Hamze, Monzer

    Published in Pathogens (Basel) (03-10-2024)
    “…This study aimed to investigate the SARS-CoV-2 infection prevalence among >18-year-old students in the Faculty of Public Health and Faculty of Sciences at the…”
    Get full text
    Journal Article
  5. 5

    Targeting the androgen receptor signaling pathway in advanced prostate cancer by Chung, Clement, Abboud, Karen

    Published in American journal of health-system pharmacy (22-07-2022)
    “…Abstract Purpose This article summarizes current androgen receptor (AR)–directed therapies that have received regulatory approval for the treatment of advanced…”
    Get full text
    Journal Article
  6. 6

    Sequencing and combination of current small‐molecule inhibitors for chronic lymphocytic leukemia: Where is the evidence? by Chung, Clement, Umoru, Godsfavour, Abboud, Karen, Hobaugh, Eleanor

    Published in European journal of haematology (01-07-2023)
    “…Small‐molecule inhibitors have revolutionized the treatment of chronic lymphocytic leukemia (CLL), a landscape once dominated by chemoimmunotherapy (i.e., an…”
    Get full text
    Journal Article
  7. 7

    Implementing Research Into Practice as a Clinical Based New Practitioner Pharmacist by Stephens, Katy, Abboud, Karen, Scott, Savanna, Lau, Maggie

    Published in Hospital pharmacy (Philadelphia) (01-12-2024)
    “…Scholarly activities are essential for enhancing the pharmacy profession, as well as for personal career development. New practitioner pharmacists in academic…”
    Get full text
    Journal Article
  8. 8
  9. 9

    The Impact of Infections in Patients Treated with Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma by Esmail, Abdullah, Xu, Jiaqiong, Burns, Ethan A, Abboud, Karen, Sheikh, Ali, Umoru, Godsfavour, Gee, Kelly, Wiechmann, Catherine, Zhang, Yuqi, Abdelrahim, Maen

    Published in Journal of clinical medicine (23-08-2024)
    “…: The therapeutic landscape of unresectable hepatocellular carcinoma (uHCC) continues to evolve. Atezolizumab, an anti-programmed cell death ligand 1 (PD-1)…”
    Get full text
    Journal Article
  10. 10

    Immune Checkpoint Inhibitors for Solid Tumors in the Adjuvant Setting: Current Progress, Future Directions, and Role in Transplant Oncology by Abboud, Karen, Umoru, Godsfavour, Esmail, Abdullah, Abudayyeh, Ala, Murakami, Naoka, Al-Shamsi, Humaid O, Javle, Milind, Saharia, Ashish, Connor, Ashton A, Kodali, Sudha, Ghobrial, Rafik M, Abdelrahim, Maen

    Published in Cancers (23-02-2023)
    “…The rationale for administering immune checkpoint inhibitors (ICIs) in the adjuvant setting is to eradicate micro-metastases and, ultimately, prolong survival…”
    Get full text
    Journal Article
  11. 11